Document Detail


High Levels of Folate From Supplements and Fortification Are Not Associated With Increased Risk of Colorectal Cancer.
MedLine Citation:
PMID:  21586288     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND & AIMS: Folate intake has been inversely associated with colorectal cancer risk in several prospective epidemiologic studies. However, no study fully assessed the influence of the high levels of folate that are frequently consumed in the United States as a result of mandatory folate fortification, which was fully implemented in 1998, and the recent increase in use of folate-containing supplements. There is evidence that consumption of high levels of folic acid, the form of folate used for fortification and in supplements, has different effects on biochemical pathways than natural folates and might promote carcinogenesis. METHODS: We investigated the association between folate intake and colorectal cancer among 43,512 men and 56,011 women in the Cancer Prevention Study II (CPS-II) Nutrition Cohort; 1023 were diagnosed with colorectal cancer between 1999 and 2007, a period entirely after folate fortification began. Cox proportional hazards regression was used to calculate multivariate hazards ratios (RR) and 95% confidence interval (CI). RESULTS: Intake of high levels of natural folate (RR(Q5vsQ1) = 0.86; 95% CI: 0.70-1.06; P trend = .12) or folic acid (RR(Q5vsQ1) = 0.84; 95% CI: 0.68-1.03; P trend = .06) were not significantly associated with risk of colorectal cancer. Total folate intake was significantly associated with lower risk (RR(Q5vsQ1) = 0.81; 95% CI: 0.66-0.99; P trend = .047). CONCLUSIONS: Intake of high levels of total folate reduces risk of colorectal cancer; there is no evidence that dietary fortification or supplementation with this vitamin increases colorectal cancer risk.
Authors:
Victoria L Stevens; Marjorie L McCullough; Juzhong Sun; Eric J Jacobs; Peter T Campbell; Susan M Gapstur
Related Documents :
22241668 - Risk of cancer in patients with inflammatory bowel disease and venous thromboembolism: ...
22098548 - Plasminogen activator inhibitor 1 rna interference suppresses gastric cancer metastasis...
21689308 - Surgical versus general practitioner assessment: diagnostic accuracy in two week wait c...
21956158 - Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxyme...
1469158 - Assessment of changes in body water by bioimpedance in acutely ill surgical patients.
15172988 - Overexpression, amplification, and androgen regulation of tpd52 in prostate cancer.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-14
Journal Detail:
Title:  Gastroenterology     Volume:  -     ISSN:  1528-0012     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-5-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0374630     Medline TA:  Gastroenterology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.
Affiliation:
Epidemiology Research Program, American Cancer Society, Atlanta, Georgia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blood-brain barrier disruption following subarchnoid hemorrhage may be faciliated through puma induc...
Next Document:  Development of an IgY-based rocket-immunoelectrophoresis for identity monitoring of Pertussis vaccin...